These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38768953)

  • 1. A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives.
    Bhuia MS; Chowdhury R; Akter MA; Ali MA; Afroz M; Akbor MS; Sonia FA; Mubarak MS; Islam MT
    Phytother Res; 2024 May; ():. PubMed ID: 38768953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
    Kim DH; Kim MJ; Sung B; Suh H; Jung JH; Chung HY; Kim ND
    Oncol Rep; 2017 Jan; 37(1):281-288. PubMed ID: 27840966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy.
    Keshavarzmotamed A; Mousavi V; Masihipour N; Rahmati A; Mousavi Dehmordi R; Ghezelbash B; Alimohammadi M; Mafi A
    Curr Mol Pharmacol; 2023 Oct; ():. PubMed ID: 37904563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol used as nanotherapeutic: a promising additional therapeutic tool against hormone-sensitive, hormone-insensitive and resistant prostate cancer.
    Badawi JK
    Am J Clin Exp Urol; 2023; 11(1):1-11. PubMed ID: 36923720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises.
    Ahmad J; Ahamad J; Algahtani MS; Garg A; Shahzad N; Ahmad MZ; Imam SS
    Expert Opin Drug Deliv; 2024 Feb; 21(2):229-244. PubMed ID: 38344809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
    Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
    Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An insight into the anticancer potentials of lignan arctiin: A comprehensive review of molecular mechanisms.
    Chowdhury R; Bhuia MS; Wilairatana P; Afroz M; Hasan R; Ferdous J; Rakib AI; Sheikh S; Mubarak MS; Islam MT
    Heliyon; 2024 Jun; 10(12):e32899. PubMed ID: 38988539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Promises of Bioactive Rosavin: A Comprehensive Review with Mechanistic Insight.
    Aktar A; Bhuia S; Chowdhury R; Hasan R; Islam Rakib A; Al Hasan S; Akter Sonia F; Torequl Islam M
    Chem Biodivers; 2024 Jul; 21(7):e202400286. PubMed ID: 38752614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells.
    Kim JA; Kim DH; Hossain MA; Kim MY; Sung B; Yoon JH; Suh H; Jeong TC; Chung HY; Kim ND
    Int J Oncol; 2014 Feb; 44(2):473-80. PubMed ID: 24316714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pharmacological Potential of Resveratrol in Reducing Soft Tissue Damage in Osteoarthritis Patients.
    Singh K; Gupta JK; Kumar S
    Curr Rheumatol Rev; 2024; 20(1):27-38. PubMed ID: 37694798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.
    Cal C; Garban H; Jazirehi A; Yeh C; Mizutani Y; Bonavida B
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):77-93. PubMed ID: 12678904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK.
    Wang J; Li J; Cao N; Li Z; Han J; Li L
    Onco Targets Ther; 2018; 11():7777-7786. PubMed ID: 30464525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.
    Vanamala J; Reddivari L; Radhakrishnan S; Tarver C
    BMC Cancer; 2010 May; 10():238. PubMed ID: 20504360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.
    Chang CH; Lee CY; Lu CC; Tsai FJ; Hsu YM; Tsao JW; Juan YN; Chiu HY; Yang JS; Wang CC
    Int J Oncol; 2017 Mar; 50(3):873-882. PubMed ID: 28197628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved.
    Bian P; Hu W; Liu C; Li L
    Arch Biochem Biophys; 2020 Aug; 689():108461. PubMed ID: 32531316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.
    Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y
    J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation.
    Ma YQ; Zhang M; Sun ZH; Tang HY; Wang Y; Liu JX; Zhang ZX; Wang C
    World J Gastrointest Oncol; 2024 Feb; 16(2):493-513. PubMed ID: 38425392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol down-regulates a glutamate-induced tissue plasminogen activator via Erk and AMPK/mTOR pathways in rat primary cortical neurons.
    Cho KS; Lee EJ; Kwon KJ; Gonzales EL; Kim YB; Cheong JH; Bahn GH; Lee J; Han SH; Kim YT; Shin CY
    Food Funct; 2014 May; 5(5):951-60. PubMed ID: 24599349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Insight into Novel Delivery Approaches of Resveratrol for Improving Therapeutic Efficacy and Bioavailability with its Clinical Updates.
    Harwansh RK; Yadav P; Deshmukh R
    Curr Pharm Des; 2023; 29(37):2921-2939. PubMed ID: 38053352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.